GEVO Form 144: 91,459 shares planned sale disclosed
Rhea-AI Filing Summary
Gevo, Inc. filed a Form 144 notifying the planned sale of 91,459 shares of common stock through Stifel Nicolaus & Company, Inc. on 08/18/2025 on Nasdaq. The filing shows the shares carry an aggregate market value of $153,258 and that the issuer has 241,839,083 shares outstanding. The securities were acquired by the seller on 05/23/2025 via an option exercise from the issuer, totaling 224,639 shares acquired; payment is indicated as cash with an indicated payment date of 08/18/2025. The filer reports no sales of the issuer's securities in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider exercised options recently and plans a modest sale of 91,459 shares, disclosed via Form 144 — routine transparency.
The Form 144 documents a planned sale executed through a broker on a single date with explicit quantities and market value. The acquisition by option exercise on 05/23/2025 and the planned sale on 08/18/2025 are clearly reported, and there are no reported sales in the prior three months. For investors, this is primarily a disclosure of insider liquidity rather than an operational signal; the quantity represents a small fraction of the total outstanding shares.
TL;DR: Filing meets Rule 144 notice requirements, showing compliance and timely disclosure of insider disposition.
The document provides required details: broker, share count, acquisition method, and representation regarding material nonpublic information. The seller certified lack of undisclosed material adverse information and noted no prior sales in the past three months, which supports procedural compliance. The sale appears to be a routine liquidity event following an option exercise rather than a governance or control change.